Vitamin D in Treating Patients With Prostate Cancer

Completed · Phase 2

Conditions studied: Prostate Cancer

In brief

RATIONALE: Vitamin D may be effective in treating patients with prostate cancer. PURPOSE: This randomized phase II trial is studying how well 4 different doses of vitamin D works in treating patients with prostate cancer.

Key facts

Study ID

NCT00524680

Run by

Roswell Park Cancer Institute

People needed

148

Starts

2007-06-01

Expected to finish

2013-03-01

Last updated by the study team

2015-11-02

Who can join

Age: 18 and older, up to 120. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• ECOG performance status 0-2
• Creatinine ≤ 2.0 mg/dL
• Corrected serum calcium ≤ 10.5 mg/dL

You may not qualify if…

• History of malabsorption syndrome (e.g., pancreatic insufficiency, celiac disease, or tropical sprue)
• Hypersensitivity to cholecalciferol or one of its components
• PRIOR CONCURRENT THERAPY:
• No other concurrent vitamin D supplementation

Where it is running

• Roswell Park Cancer Institute — Buffalo, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.